Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials

CONCLUSION: Treatment with beta-blockers prevents dilatation of the left ventricle, development of diastolic dysfunction, and reduction of LVEF. However, these hemodynamic effects do not translate into a significant reduction in CTRCD incidence and prevention of hospitalization for heart failure or cardiac death.PMID:36687509 | PMC:PMC9818032 | DOI:10.1155/2022/8367444

Source: Cancer Control - January 23, 2023 Category: Cancer & Oncology Authors: Armin Attar Arman Karimi Behnagh Mehrasa Hosseini Foad Amanollahi Paria Shafiekhani Ali Kabir Source Type: research